| Primary |
| Type 2 Diabetes Mellitus |
49.8% |
| Diabetes Mellitus |
30.4% |
| Diabetes Mellitus Non-insulin-dependent |
10.2% |
| Drug Use For Unknown Indication |
2.7% |
| Product Used For Unknown Indication |
2.0% |
| Hypertension |
1.3% |
| Insulin-requiring Type Ii Diabetes Mellitus |
0.5% |
| Blood Glucose Increased |
0.4% |
| Blood Glucose Abnormal |
0.4% |
| Depression |
0.3% |
| Diabetes Mellitus Inadequate Control |
0.3% |
| Hyperlipidaemia |
0.3% |
| Hyperglycaemia |
0.2% |
| Polycystic Ovaries |
0.2% |
| Type 1 Diabetes Mellitus |
0.2% |
| Blood Cholesterol Increased |
0.2% |
| Hiv Infection |
0.2% |
| Dyslipidaemia |
0.1% |
| Glucose Tolerance Impaired |
0.1% |
| Back Pain |
0.1% |
|
| Bladder Cancer |
57.8% |
| Weight Increased |
11.5% |
| Bladder Transitional Cell Carcinoma |
5.4% |
| Myocardial Infarction |
4.2% |
| Haematuria |
2.2% |
| Oedema Peripheral |
2.1% |
| Pleural Effusion |
1.5% |
| Pulmonary Oedema |
1.4% |
| Weight Decreased |
1.3% |
| Bladder Neoplasm |
1.3% |
| Cardiac Failure Congestive |
1.3% |
| Vision Blurred |
1.3% |
| Vomiting |
1.3% |
| Prostate Cancer |
1.2% |
| Transitional Cell Carcinoma |
1.2% |
| Pharmaceutical Product Complaint |
1.1% |
| Cerebrovascular Accident |
1.1% |
| Renal Cancer |
1.0% |
| Treatment Noncompliance |
1.0% |
| Oedema |
0.9% |
|
| Secondary |
| Diabetes Mellitus |
27.8% |
| Type 2 Diabetes Mellitus |
23.8% |
| Hypertension |
12.5% |
| Drug Use For Unknown Indication |
9.8% |
| Product Used For Unknown Indication |
4.4% |
| Depression |
3.6% |
| Diabetes Mellitus Non-insulin-dependent |
3.1% |
| Hyperlipidaemia |
1.7% |
| Blood Cholesterol Increased |
1.4% |
| Tachyarrhythmia |
1.2% |
| Dyslipidaemia |
1.2% |
| Pain |
1.2% |
| Congestive Cardiomyopathy |
1.1% |
| Hypercholesterolaemia |
1.1% |
| Hypertriglyceridaemia |
1.1% |
| Hyperuricaemia |
1.1% |
| Oedema |
1.1% |
| Hiv Infection |
1.0% |
| Insomnia |
1.0% |
| Angina Pectoris |
0.8% |
|
| Weight Increased |
16.4% |
| Hypoglycaemia |
10.7% |
| Oedema Peripheral |
8.1% |
| Weight Decreased |
7.3% |
| Renal Failure Acute |
6.7% |
| Bladder Cancer |
5.1% |
| Blood Glucose Increased |
5.1% |
| Myocardial Infarction |
4.9% |
| Drug Ineffective |
4.5% |
| Liver Injury |
3.8% |
| Oedema |
3.8% |
| Vomiting |
3.4% |
| Tremor |
3.2% |
| Liver Disorder |
2.8% |
| Vision Blurred |
2.8% |
| Diarrhoea |
2.4% |
| Loss Of Consciousness |
2.4% |
| Macular Oedema |
2.4% |
| Renal Impairment |
2.4% |
| Renal Disorder |
2.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
21.5% |
| Diabetes Mellitus |
16.9% |
| Drug Use For Unknown Indication |
12.8% |
| Type 2 Diabetes Mellitus |
12.6% |
| Hypertension |
8.6% |
| Diabetes Mellitus Non-insulin-dependent |
6.5% |
| Blood Cholesterol Increased |
2.8% |
| Depression |
2.5% |
| Pain |
2.4% |
| Prophylaxis |
1.8% |
| Rheumatoid Arthritis |
1.6% |
| Gastrooesophageal Reflux Disease |
1.3% |
| Hyperlipidaemia |
1.2% |
| Osteoporosis |
1.2% |
| Asthma |
1.1% |
| Anxiety |
1.1% |
| Blood Cholesterol |
1.0% |
| Atrial Fibrillation |
1.0% |
| Blood Pressure |
0.9% |
| Bipolar Disorder |
0.9% |
|
| Weight Decreased |
27.4% |
| Vomiting |
9.2% |
| Blood Glucose Increased |
8.5% |
| Nausea |
7.3% |
| Weight Increased |
7.0% |
| Myocardial Infarction |
4.4% |
| Type 2 Diabetes Mellitus |
4.1% |
| Pancreatitis |
3.6% |
| Tremor |
3.5% |
| Drug Ineffective |
3.2% |
| Flushing |
2.7% |
| Pain |
2.6% |
| Rash |
2.4% |
| Vision Blurred |
2.3% |
| Pancreatitis Acute |
2.1% |
| Oedema Peripheral |
2.1% |
| Death |
1.9% |
| Pneumonia |
1.9% |
| Diarrhoea |
1.9% |
| Pruritus |
1.9% |
|
| Interacting |
| Diabetes Mellitus |
25.9% |
| Depression |
12.7% |
| Product Used For Unknown Indication |
7.1% |
| Hypertension |
6.1% |
| Tachyarrhythmia |
6.1% |
| Type 2 Diabetes Mellitus |
6.1% |
| Blood Cholesterol |
5.1% |
| Blood Pressure |
4.6% |
| Non-small Cell Lung Cancer |
4.1% |
| Atrial Fibrillation |
3.0% |
| Dyslipidaemia |
3.0% |
| Drug Use For Unknown Indication |
2.5% |
| High Density Lipoprotein Decreased |
2.5% |
| Blood Cholesterol Increased |
2.0% |
| Cardiac Failure Congestive |
2.0% |
| Hiv Infection |
1.5% |
| Hypercholesterolaemia |
1.5% |
| Hyperlipidaemia |
1.5% |
| Weight Loss Diet |
1.5% |
| Gastrointestinal Mucosal Disorder |
1.0% |
|
| Myocardial Infarction |
20.0% |
| Nasopharyngitis |
13.3% |
| Weight Increased |
13.3% |
| Swelling |
10.0% |
| Drug Interaction |
6.7% |
| Myositis |
6.7% |
| Rhabdomyolysis |
6.7% |
| Medication Error |
3.3% |
| Overdose |
3.3% |
| Pain |
3.3% |
| Pollakiuria |
3.3% |
| Renal Failure Acute |
3.3% |
| Renal Impairment |
3.3% |
| Urinary Tract Infection |
3.3% |
|
